BRM and BRG1 mediate chromatin remodeling by binding to AHR target loci and recruiting steroid receptor coactivator 1 (SRC-1), steroid receptor coactivator 2 (SRC-2) and p300, a nuclear receptor coactivator in breast cancer cells [25]. Here, AHR is linked to breast cancer.